1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Cancer (Tumor) Profiling Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Immunoassay
  • 1.2.3 Hybridization
  • 1.2.4 NGS
  • 1.2.5 Mass Spectrometry
• 1.3 Market by Application
  • 1.3.1 Global Cancer (Tumor) Profiling Market Share by Application: 2020 VS 2026
  • 1.3.2 Clinical
  • 1.3.3 Research
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Cancer (Tumor) Profiling Market Perspective (2015-2026)
• 2.2 Global Cancer (Tumor) Profiling Growth Trends by Regions
  • 2.2.1 Cancer (Tumor) Profiling Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Cancer (Tumor) Profiling Historic Market Share by Regions (2015-2020)
  • 2.2.3 Cancer (Tumor) Profiling Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Cancer (Tumor) Profiling Players by Market Size
  • 3.1.1 Global Top Cancer (Tumor) Profiling Players by Revenue (2015-2020)
  • 3.1.2 Global Cancer (Tumor) Profiling Revenue Market Share by Players (2015-2020)
• 3.2 Global Cancer (Tumor) Profiling Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Cancer (Tumor) Profiling Revenue
• 3.4 Global Cancer (Tumor) Profiling Market Concentration Ratio
  • 3.4.1 Global Cancer (Tumor) Profiling Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Cancer (Tumor) Profiling Revenue in 2019
• 3.5 Key Players Cancer (Tumor) Profiling Area Served
• 3.6 Key Players Cancer (Tumor) Profiling Product Solution and Service
• 3.7 Date of Enter into Cancer (Tumor) Profiling Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer (Tumor) Profiling Breakdown Data by Type (2015-2026)

• 4.1 Global Cancer (Tumor) Profiling Historic Market Size by Type (2015-2020)
• 4.2 Global Cancer (Tumor) Profiling Forecasted Market Size by Type (2021-2026)

5 Cancer (Tumor) Profiling Breakdown Data by Application (2015-2026)

• 5.1 Global Cancer (Tumor) Profiling Historic Market Size by Application (2015-2020)
• 5.2 Global Cancer (Tumor) Profiling Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Cancer (Tumor) Profiling Market Size (2015-2026)
• 6.2 North America Cancer (Tumor) Profiling Market Size by Type (2015-2020)
• 6.3 North America Cancer (Tumor) Profiling Market Size by Application (2015-2020)
• 6.4 North America Cancer (Tumor) Profiling Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Cancer (Tumor) Profiling Market Size (2015-2026)
• 7.2 Europe Cancer (Tumor) Profiling Market Size by Type (2015-2020)
• 7.3 Europe Cancer (Tumor) Profiling Market Size by Application (2015-2020)
• 7.4 Europe Cancer (Tumor) Profiling Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Cancer (Tumor) Profiling Market Size (2015-2026)
• 8.2 China Cancer (Tumor) Profiling Market Size by Type (2015-2020)
• 8.3 China Cancer (Tumor) Profiling Market Size by Application (2015-2020)
• 8.4 China Cancer (Tumor) Profiling Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Cancer (Tumor) Profiling Market Size (2015-2026)
• 9.2 Japan Cancer (Tumor) Profiling Market Size by Type (2015-2020)
• 9.3 Japan Cancer (Tumor) Profiling Market Size by Application (2015-2020)
• 9.4 Japan Cancer (Tumor) Profiling Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Cancer (Tumor) Profiling Market Size (2015-2026)
• 10.2 Southeast Asia Cancer (Tumor) Profiling Market Size by Type (2015-2020)
• 10.3 Southeast Asia Cancer (Tumor) Profiling Market Size by Application (2015-2020)
• 10.4 Southeast Asia Cancer (Tumor) Profiling Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Illumina
  • 11.1.1 Illumina Company Details
  • 11.1.2 Illumina Business Overview
  • 11.1.3 Illumina Cancer (Tumor) Profiling Introduction
  • 11.1.4 Illumina Revenue in Cancer (Tumor) Profiling Business (2015-2020))
  • 11.1.5 Illumina Recent Development
• 11.2 Qiagen
  • 11.2.1 Qiagen Company Details
  • 11.2.2 Qiagen Business Overview
  • 11.2.3 Qiagen Cancer (Tumor) Profiling Introduction
  • 11.2.4 Qiagen Revenue in Cancer (Tumor) Profiling Business (2015-2020)
  • 11.2.5 Qiagen Recent Development
• 11.3 Neogenomics Laboratories
  • 11.3.1 Neogenomics Laboratories Company Details
  • 11.3.2 Neogenomics Laboratories Business Overview
  • 11.3.3 Neogenomics Laboratories Cancer (Tumor) Profiling Introduction
  • 11.3.4 Neogenomics Laboratories Revenue in Cancer (Tumor) Profiling Business (2015-2020)
  • 11.3.5 Neogenomics Laboratories Recent Development
• 11.4 HTG Molecular Diagnostics
  • 11.4.1 HTG Molecular Diagnostics Company Details
  • 11.4.2 HTG Molecular Diagnostics Business Overview
  • 11.4.3 HTG Molecular Diagnostics Cancer (Tumor) Profiling Introduction
  • 11.4.4 HTG Molecular Diagnostics Revenue in Cancer (Tumor) Profiling Business (2015-2020)
  • 11.4.5 HTG Molecular Diagnostics Recent Development
• 11.5 Genomic Health
  • 11.5.1 Genomic Health Company Details
  • 11.5.2 Genomic Health Business Overview
  • 11.5.3 Genomic Health Cancer (Tumor) Profiling Introduction
  • 11.5.4 Genomic Health Revenue in Cancer (Tumor) Profiling Business (2015-2020)
  • 11.5.5 Genomic Health Recent Development
• 11.6 Caris Life Sciences
  • 11.6.1 Caris Life Sciences Company Details
  • 11.6.2 Caris Life Sciences Business Overview
  • 11.6.3 Caris Life Sciences Cancer (Tumor) Profiling Introduction
  • 11.6.4 Caris Life Sciences Revenue in Cancer (Tumor) Profiling Business (2015-2020)
  • 11.6.5 Caris Life Sciences Recent Development
• 11.7 Helomics Corporation
  • 11.7.1 Helomics Corporation Company Details
  • 11.7.2 Helomics Corporation Business Overview
  • 11.7.3 Helomics Corporation Cancer (Tumor) Profiling Introduction
  • 11.7.4 Helomics Corporation Revenue in Cancer (Tumor) Profiling Business (2015-2020)
  • 11.7.5 Helomics Corporation Recent Development
• 11.8 Nanostring Technologies
  • 11.8.1 Nanostring Technologies Company Details
  • 11.8.2 Nanostring Technologies Business Overview
  • 11.8.3 Nanostring Technologies Cancer (Tumor) Profiling Introduction
  • 11.8.4 Nanostring Technologies Revenue in Cancer (Tumor) Profiling Business (2015-2020)
  • 11.8.5 Nanostring Technologies Recent Development
• 11.9 Oxford Gene Technology
  • 11.9.1 Oxford Gene Technology Company Details
  • 11.9.2 Oxford Gene Technology Business Overview
  • 11.9.3 Oxford Gene Technology Cancer (Tumor) Profiling Introduction
  • 11.9.4 Oxford Gene Technology Revenue in Cancer (Tumor) Profiling Business (2015-2020)
  • 11.9.5 Oxford Gene Technology Recent Development
• 11.10 Ribomed Biotechnologies
  • 11.10.1 Ribomed Biotechnologies Company Details
  • 11.10.2 Ribomed Biotechnologies Business Overview
  • 11.10.3 Ribomed Biotechnologies Cancer (Tumor) Profiling Introduction
  • 11.10.4 Ribomed Biotechnologies Revenue in Cancer (Tumor) Profiling Business (2015-2020)
  • 11.10.5 Ribomed Biotechnologies Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Cancer (Tumor) Profiling Scope and Market Size
Cancer (Tumor) Profiling market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer (Tumor) Profiling market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Immunoassay
Hybridization
NGS
Mass Spectrometry

Market segment by Application, split into
Clinical
Research

Based on regional and country-level analysis, the Cancer (Tumor) Profiling market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Cancer (Tumor) Profiling market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Illumina
Qiagen
Neogenomics Laboratories
HTG Molecular Diagnostics
Genomic Health
Caris Life Sciences
Helomics Corporation
Nanostring Technologies
Oxford Gene Technology
Ribomed Biotechnologies